Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiri Guy-Alfandary

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2021
Shelley A Sternberg, Shiri Guy-Alfandary, Paula A Rochon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 9, 2021
Prescribing cascades in older adultsShelley A Sternberg, Shiri Guy-Alfandary, Paula A Rochon
Seizure|January 6, 2016
An evaluation of pharmacist knowledge on treatment with antiepileptic drugsYifat Roth, Miri Y Neufeld, Ilan Blatt, et al.
Clinical Pharmacology and Therapeutics|May 6, 2022
Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector CollaborationShiri Guy-Alfandary, Sasha Zhurat, Maya Berlin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2021
Shelley A Sternberg, Shiri Guy-Alfandary, Paula A Rochon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 9, 2021
Prescribing cascades in older adultsShelley A Sternberg, Shiri Guy-Alfandary, Paula A Rochon
Seizure|January 6, 2016
An evaluation of pharmacist knowledge on treatment with antiepileptic drugsYifat Roth, Miri Y Neufeld, Ilan Blatt, et al.
Clinical Pharmacology and Therapeutics|May 6, 2022
Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector CollaborationShiri Guy-Alfandary, Sasha Zhurat, Maya Berlin, et al.
Pageof 1